Symbiotec Pharmalab Ltd 52 Week Low
Symbiotec Pharmalab Ltd
NSE: SYMBIOTEC
YEARLOW
Key Highlights
- The 52 Week Low of Symbiotec Pharmalab Ltd is ₹ 933.8 as of 30 Sep 26 .
Company Fundamentals for Symbiotec Pharmalab Ltd
Market Price of Symbiotec Pharmalab Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 30 Sep 2026 | 1176.05 |
| 29 Sep 2026 | 1144.35 |
| 28 Sep 2026 | 1056.75 |
| 25 Sep 2026 | 1002.55 |
| 24 Sep 2026 | 1024.95 |
| 23 Sep 2026 | 1062.15 |
| 22 Sep 2026 | 1121.25 |
| 21 Sep 2026 | 1158.45 |
| 18 Sep 2026 | 1093.25 |
| 17 Sep 2026 | 1046.8 |
Asset Value vs Market Value of Symbiotec Pharmalab Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Historical Revenue of Symbiotec Pharmalab Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Symbiotec Pharmalab Ltd
Historical Net Profit of Symbiotec Pharmalab Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Symbiotec Pharmalab Ltd
Symbiotec Pharmalab Ltd News Hub
Symbiotec Pharmalab to announce Quarterly Result
Symbiotec Pharmalab will hold a meeting of the Board of Directors of the Company on 21 September 202
Read more
12 Sept 26
Symbiotec Pharmalab posts nearly 53% YoY fall in Q1 PAT
Reported EBIDTA declined by 22.1% year-on-year (YoY) to Rs 45.2 crore while reported EBIDTA margin c
Read more
22 Sept 26
Symbiotec Pharmalab IPO ends with 71.26 times subcription
The initial public offer of Symbiotec Pharmalab received bids for 93,52,49,700 shares as against 1,3
Read more
28 Aug 26
Symbiotec Pharmalab consolidated net profit declines 53.01% in the June 2026 quarter
Net profit of Symbiotec Pharmalab declined 53.01% to Rs 14.06 crore in the quarter ended June 2026 a
Read more
23 Sept 26
